Transcatheter aortic valve implantation with the CoreValve for the treatment of rheumatic aortic stenosis

References (1)

1. Sarkar K, Sardella G, Romeo F, De Benedictis M, Tarsia G, Iadanza A, et al. Transcatheter aortic valve implantation for severe regurgitation in native and degenerated bioprosthetic aortic valves. Catheter Cardiovasc Interv 2013; 81: 864-70. [CrossRef] 2. Hildebrandt HA, Erbel R, Kahlert P Compassionate use of the self- expandable Medtronic CoreValve prosthesis for the treatment of pure aortic regurgitation in a patient at prohibitive risk for surgical valve replacement. Catheter Cardiovasc Interv 2013; 82: 939-43. [CrossRef] 3. Roy DA, Schaefer U, Guetta V, Hildick-Smith D, Möllmann H, Dumonteil N, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol 2013; 61: 1577-84. [CrossRef] 4. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv 2008; 1: 167-75. [CrossRef] 5. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio- Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-96. [CrossRef]